McDonald’s Corp. has finally updated its antibiotics policy that calls for reduced antibiotic usage after a two-year delay.
The fast-food giant’s new policy revealed in Decemebr follows guidelines set out by the World Health Organization (WHO), the World Organization for Animal Health, and other public and animal health groups.
According to McDonald’s, they will focus on the responsible use of medically important antibiotics and be aligned with WHO Guidelines on Antimicrobial Resistance.
The company added that its policy does not permit the routine use of medically important antibiotics for growth promotion or tdisease prevention.
It is committed to usage reduction, where possible without adverse effects on animal health and welfare.
The company has established market-specific targets for the responsible use of antibiotics for 10 in-scope markets, representing over 80 percent of its global beef supply chain.
In 2023, McDonald’s plans to share an update on its antibiotic usage.
However, the Natural Resources Defense Council (NRDC) criticized McDonald’s for failing to detail a rollout plan or a completion date to ensure accountability across the supply chain.
According to Lena Brook, director of food campaigns at NRDC, it is especially disappointing given that McDonald’s, the world’s largest beef buyer, chose optics over substance with its new beef policy update despite the urgency of the global antibiotic resistance crisis.
McDonald’s earned a grade of C from the NDRC for its previous policy. NDRC called McDonald’s updated policy a “new, weaker approach.”


AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025
Trump Threatens Aircraft Tariffs as U.S.-Canada Jet Certification Dispute Escalates
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Gold, Silver, and Platinum Rally as Precious Metals Recover from Sharp Selloff
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom
Nvidia Confirms Major OpenAI Investment Amid AI Funding Race
Hyundai Motor Lets Russia Plant Buyback Option Expire Amid Ongoing Ukraine War
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Using the Economic Calendar to Reduce Surprise Driven Losses in Forex
Japan Finance Minister Defends PM Takaichi’s Remarks on Weak Yen Benefits
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Oil Prices Steady as Markets Weigh U.S.-Iran Talks, Dollar Strength Caps Gains
Disney Board Nears CEO Decision as Josh D’Amaro Emerges as Leading Candidate
India Budget 2025 Highlights Manufacturing Push but Falls Short of Market Expectations
Dollar Holds Firm as Strong U.S. Data, Fed Expectations and Global Central Bank Moves Shape Markets 



